Roche ramps up AI computing capacity with Nvidia chip expansion
Roche deployed 2,176 NVIDIA Blackwell GPUs across U.S. and European sites to accelerate drug discovery, modeling, and clinical trials, creating the largest GPU footprint in pharma.
8 Articles
8 Articles
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions
With the addition of 2,176 NVIDIA Blackwell GPUs, Roche now operates the pharmaceutical industry’s largest announced hybrid-cloud AI factory, totaling more than 3,500 GPUs. The...
Roche Expands AI Infrastructure For Drug Discovery With NVIDIA GPUs
Roche is significantly expanding its AI capabilities with over 3,500 NVIDIA GPUs, bolstering its efforts in areas like drug discovery. This investment provides the pharmaceutical giant with increased computing power to accelerate scientific projects utilizing nvidia drug discovery GPUs.
Roche claims pharma’s largest GPU footprint at NVIDIA’s flagship GTC event
In May 2024, Recursion Pharmaceuticals unveiled BioHive-2, a 504-GPU supercomputer it called the largest in the pharmaceutical industry. Nearly two years later, Roche claims to have almost seven times that number, and none of the companies in this emerging GPU arms race has publicly tied a specific clinical candidate to its AI infrastructure. Roche deployed… The post Roche claims pharma’s largest GPU footprint at NVIDIA’s flagship GTC event appe…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




